Signal12 Pharmaceuticals has aligned with the FDA on its phase 3 clinical trial strategy for Pro-ocular, a novel drop-free ...
The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...
COAST Phase 3 trial failed to meet primary endpoint of mean change in BCVA from baseline to week 52Opthea considering impact of negative trial ...
Discover how Moleculin Biotech advances Annamycin's Phase 3 trial for AML treatment, with key milestones planned through 2025.
Researchers at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai have demonstrated the potential for a new combination therapy to improve outcomes for patients with ...
The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory ...
An even greater challenge is their need for external investment. During the early stages of development, in order to progress ...
Peeples Cancer Institute at Hamilton Medical Center has expanded access to the latest in cancer research for patients in ...
Clinical Trials Arena on MSN18h
FDA aligns with Imunon’s Phase III trial protocol for ovarian cancer treatmentImunon is initiating sites for the trial and collaborating with investigators to commence participant enrolment.
The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugsRamat Gan, Israel, March 24, 2025 (GLOBE ...
Transparent, well-designed clinical trials are a must. FastWave Medical's Scott Nelson has advice on how to get there.
Despite advances in anticoagulant therapies, bleeding remains a critical concern.Traditionally, the definition of major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback